Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.92
(-2.38%)
CNY 4.92
(-2.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 600.09 Million | 545.36 Million | 527.44 Million | 1.07 Billion | 491.68 Million | 479.82 Million |
| Cost of Revenue | 566.33 Million | 473.18 Million | 418.18 Million | 709.14 Million | 385.7 Million | 367.27 Million |
| Gross Profit | 33.76 Million | 72.18 Million | 109.25 Million | 363.25 Million | 105.98 Million | 112.55 Million |
| Operating Expenses | 180.58 Million | 87.31 Million | 104.77 Million | 205.44 Million | 69.12 Million | 73.54 Million |
| Selling, General and Administrative Expenses | 25.73 Million | 23.15 Million | 38.46 Million | 135.37 Million | 23.79 Million | 30.15 Million |
| Research and Development Expenses | 28.18 Million | 27.72 Million | 30.62 Million | 33.96 Million | 22.29 Million | 20.08 Million |
| Other Expenses | 126.66 Million | 36.42 Million | 35.69 Million | 36.1 Million | 23.03 Million | -758.01 Thousand |
| Cost and Expenses | 746.91 Million | 560.49 Million | 522.96 Million | 914.58 Million | 454.82 Million | 440.81 Million |
| Operating Income | -146.82 Million | -396.06 Thousand | 6.66 Million | 163.77 Million | 44.95 Million | 45.32 Million |
| Interest Expense | 23.18 Million | 20.17 Million | 11.79 Million | 7.59 Million | 6.55 Million | 6.95 Million |
| Income Tax Expense | -1.23 Million | -14.4 Million | -7.64 Million | 11.6 Million | 2.89 Million | 7.75 Million |
| Earnings before Tax | -148.51 Million | -29.34 Million | -30.68 Million | 109.88 Million | 28.05 Million | 44.56 Million |
| Net Income | -147.41 Million | -14.93 Million | -23.03 Million | 98.06 Million | 28.05 Million | 39.25 Million |
| Earnings Per Share Basic | -0.51 | -0.05 | -0.08 | 0.34 | 0.10 | 0.14 |
| Earnings Per Share Diluted | -0.51 | -0.05 | -0.08 | 0.34 | 0.10 | 0.14 |
| Weighted Average Shares Outstanding | 289.05 Million | 289.04 Million | 292.47 Million | 292.73 Million | 285.6 Million | 285.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 289.05 Million | 289.04 Million | 292.47 Million | 292.73 Million | 285.6 Million | 288.4 Million |
| Gross Margin | 0.06 | 0.13 | 0.21 | 0.34 | 0.22 | 0.23 |
| EBIT Margin | -0.13 | 0.08 | 0.07 | 0.17 | 0.12 | 0.14 |
| Profit Margin | -0.25 | -0.03 | -0.04 | 0.09 | 0.06 | 0.08 |
| EBITDA | -76.01 Million | 28.28 Million | 12.86 Million | 132.93 Million | 49.85 Million | 64.13 Million |
| Earnings Before Tax Margin | -0.24 | -0.00 | 0.01 | 0.15 | 0.09 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 151.69 Million | 160.65 Million | 137.54 Million | 600.09 Million | 129.78 Million | 117.44 Million |
| Cost of Revenue | 141.04 Million | 140.41 Million | 121.78 Million | 544.42 Million | 146.15 Million | 100.82 Million |
| Gross Profit | 10.65 Million | 20.23 Million | 15.76 Million | 55.66 Million | -16.37 Million | 16.61 Million |
| Operating Expenses | 25.31 Million | 17.13 Million | 15.93 Million | 92.13 Million | 24.22 Million | 19.71 Million |
| Selling, General and Administrative Expenses | 18.25 Million | 7.15 Million | 12.27 Million | - | -17.89 Million | 34.15 Million |
| Research and Development Expenses | 8.12 Million | 7.95 Million | 6.65 Million | - | 7.78 Million | 5.58 Million |
| Other Expenses | -25.31 Million | -2.02 Million | 2.98 Million | -1.69 Million | -1.54 Million | -181.46 Thousand |
| Cost and Expenses | 166.36 Million | 157.55 Million | 137.71 Million | 636.56 Million | 170.38 Million | 120.54 Million |
| Operating Income | -14.66 Million | 3.09 Million | -172.8 Thousand | -146.82 Million | -154.36 Million | -1.22 Million |
| Interest Expense | 1.54 Million | 5.54 Million | 946.68 Thousand | 23.18 Million | 15.74 Million | 2.14 Million |
| Income Tax Expense | 182.47 Thousand | 452.38 Thousand | 157.85 Thousand | -1.23 Million | -1.19 Million | -697.77 Thousand |
| Earnings before Tax | -16.99 Million | -2.25 Million | -76.01 Thousand | -148.51 Million | -155.91 Million | -1.22 Million |
| Net Income | -14.33 Million | -718.6 Thousand | 1.74 Million | -147.41 Million | -154.67 Million | -637.75 Thousand |
| Earnings Per Share Basic | -0.05 | -0.00 | 0.01 | - | -0.54 | -0.00 |
| Earnings Per Share Diluted | -0.05 | -0.00 | 0.01 | - | -0.54 | -0.00 |
| Weighted Average Shares Outstanding | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million | 289.04 Million |
| Gross Margin | 0.07 | 0.13 | 0.11 | 0.09 | -0.13 | 0.14 |
| EBIT Margin | -0.10 | 0.11 | -0.00 | - | -0.34 | 0.00 |
| Profit Margin | -0.09 | -0.00 | 0.01 | -0.25 | -1.19 | -0.01 |
| EBITDA | -15.45 Million | 17.07 Million | -426.1 Thousand | - | -43.74 Million | 169.65 Thousand |
| Earnings Before Tax Margin | -0.10 | 0.02 | -0.00 | -0.24 | -1.19 | -0.01 |
002920
600654
1608
GURN
0976
GSF